Among APs, FGAs (arranged according to the inductive ability: flupentixol > droperidol > fluphenazine ≈ trifluoperazine > haloperidol ≈ levomepromazine > loxapine ≈ sulpiride > chlorprothixene) and SGAs (zotepine > quetiapine) had the potential to induce LRP1 expression and thus rescue the patients from the risk of hyperlipidemia. The gene discussed is LRP1; the disease is hyperlipidemia.